Published in Clin Microbiol Rev on July 01, 1993
A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol (1998) 4.79
Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol (2002) 3.30
Rapid detection of Clostridium difficile in feces by real-time PCR. J Clin Microbiol (2003) 3.08
Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile. J Clin Microbiol (2000) 1.91
Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. J Clin Microbiol (1998) 1.89
Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens. J Clin Microbiol (1994) 1.56
Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease. J Clin Microbiol (1994) 1.47
Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol (2003) 1.43
Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile. J Mol Diagn (2008) 1.41
Rho proteins play a critical role in cell migration during the early phase of mucosal restitution. J Clin Invest (1997) 1.40
Evaluation of two rapid assays for detection of Clostridium difficile toxin A in stool specimens. J Clin Microbiol (1999) 1.23
Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun (2001) 1.23
Isolation of Helicobacter canis from a colony of bengal cats with endemic diarrhea. J Clin Microbiol (1999) 1.16
Structural basis for substrate recognition in the enzymatic component of ADP-ribosyltransferase toxin CDTa from Clostridium difficile. J Biol Chem (2009) 1.00
Etiological agents of infectious diarrhea: implications for requests for microbial culture. J Clin Microbiol (1997) 0.95
Evaluation of three commercial enzyme immunoassay kits for detecting faecal Clostridium difficile toxins. J Clin Pathol (1994) 0.90
Traditional and molecular techniques for the study of emerging bacterial diseases: one laboratory's perspective. Emerg Infect Dis (2002) 0.85
Molecular epidemiology of Clostridium difficile at a medical center in Taiwan: persistence of genetically clustering of A⁻B⁺ isolates and increase of A⁺B⁺ isolates. PLoS One (2013) 0.82
Diarrhea recurrence in patients with Clostridium difficile-associated diarrhea: Role of concurrent antibiotics. Can J Infect Dis (1999) 0.78
Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A. PLoS One (2015) 0.77
Recombinant lipoprotein-based vaccine candidates against C. difficile infections. J Biomed Sci (2015) 0.75
A review on laboratory tests' utilization: A trigger for cutting costs and quality improvement in health care settings. Med J Islam Repub Iran (2016) 0.75
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med (1978) 14.65
Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol (1979) 12.54
Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet (1978) 11.99
Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin. Lancet (1977) 8.77
Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J (1978) 8.47
Nosocomial acquisition of Clostridium difficile infection. N Engl J Med (1989) 7.72
Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis (1977) 7.68
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88
Diagnosis of pseudomembranous colitis. Br Med J (1978) 5.96
Clindamycin-associated colitis. A prospective study. Ann Intern Med (1974) 5.92
Aetiology of antimicrobial-agent-associated colitis. Lancet (1978) 5.91
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Comparison of two toxins produced by Clostridium difficile. Infect Immun (1981) 5.16
Biological activities of toxins A and B of Clostridium difficile. Infect Immun (1982) 4.62
Cytotoxicity assay in antibiotic-associated colitis. J Infect Dis (1979) 4.39
Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol (1982) 4.35
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Pseudomembranous colitis: Presence of clostridial toxin. Lancet (1978) 4.30
Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun (1990) 4.06
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology (1981) 4.04
Pseudomembranous colitis. J Clin Pathol (1977) 3.93
Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun (1978) 3.93
Clinical and laboratory observations in Clostridium difficile colitis. Am J Clin Nutr (1980) 3.89
Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis (1981) 3.76
Clostridium difficile: isolation and characteristics. J Med Microbiol (1976) 3.55
Clostridium defficiel in the urogenital tract of males and females. Lancet (1975) 3.51
Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol (1983) 3.40
Colitis induced by Clostridium difficile. Rev Infect Dis (1980) 3.15
Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens. J Infect Dis (1984) 3.07
Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med (1986) 3.06
THE SHWARTZMAN REACTION: PATHOGENETIC MECHANISMS AND CLINICAL MANIFESTATIONS. Annu Rev Med (1965) 3.02
Antibiotic-associated pseudomembranous colitis. Rev Infect Dis (1980) 3.02
Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res (1990) 2.93
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89
Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin. J Clin Microbiol (1979) 2.86
Pseudomembranous enterocolitis (antibiotic-related colitis). Adv Intern Med (1977) 2.73
Purification and characterization of Clostridium difficile toxin. Infect Immun (1979) 2.71
Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun (1982) 2.65
Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage. Gastroenterology (1978) 2.63
A family of clostridial and streptococcal ligand-binding proteins with conserved C-terminal repeat sequences. Mol Microbiol (1991) 2.62
Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Rev Infect Dis (1980) 2.59
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol (1982) 2.52
Clindamycin-associated colitis. Review of the clinical spectrum of 47 cases. Am J Dig Dis (1976) 2.52
Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol (1991) 2.51
Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A. J Clin Microbiol (1985) 2.46
Clindamycin-induced enterocolitis in hamsters. J Infect Dis (1978) 2.43
Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins. Infect Immun (1978) 2.39
Postoperative pseudomembranous enterocolitis. Surg Gynecol Obstet (1954) 2.36
Rapid detection of Clostridium difficile toxin in human feces. J Clin Microbiol (1980) 2.33
Bile acid transformations by microbial strains belonging to genera found in intestinal contents. Acta Pathol Microbiol Scand (1967) 2.33
Inappropriate testing for diarrheal diseases in the hospital. JAMA (1990) 2.31
Partial purification and characterization of a cytotoxin from Clostridium difficile. Rev Infect Dis (1980) 2.31
Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. Rev Infect Dis (1984) 2.26
Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis. J Clin Microbiol (1980) 2.24
The pseudomembranous colitis associated with clindamycin therapy--a viral colitis. Gut (1975) 2.22
Epidemiology of Clostridium difficile in infants. J Infect Dis (1982) 2.20
Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J Clin Microbiol (1992) 2.18
Fatal enterocolitis in hamsters given lincomycin hydrochloride. Lab Anim Care (1968) 2.17
Clostridium difficile in gnotobiotic mice. Infect Immun (1980) 2.17
Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis (1985) 2.16
Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies. Infect Immun (1982) 2.14
Rapid detection and presumptive identification of Clostridium difficile by p-cresol production on a selective medium. J Clin Pathol (1981) 2.14
Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces. Rev Infect Dis (1992) 2.10
Simplified procedure for the routine isolation of Clostridium difficile from faeces. J Clin Pathol (1981) 2.07
Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis (1983) 2.03
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun (1986) 2.01
Recovery of Clostridium difficile from children. Scand J Infect Dis (1981) 2.01
Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet (1992) 2.00
Purification and properties of Clostridium difficile cytotoxin B. J Biol Chem (1986) 1.97
Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut (1986) 1.93
Commercial latex test for Clostridium difficile toxin A does not detect toxin A. J Clin Microbiol (1986) 1.92
Isolation of Clostridium difficile from patients and the environment of hospital wards. J Clin Pathol (1983) 1.89
Clostridium difficile toxin in asymptomatic neonates. J Pediatr (1982) 1.88
Differential effects of Clostridium difficile toxins on tissue-cultured cells. J Clin Microbiol (1982) 1.87
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae. Gastroenterology (1980) 1.84
Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin. Gastroenterology (1979) 1.80
Diarrhea and colitis associated with antimicrobial therapy in man and animals. Am J Clin Nutr (1979) 1.76
Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin. J Clin Microbiol (1982) 1.75
Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis. Am J Clin Nutr (1980) 1.73
Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. Infect Immun (1987) 1.72
Staphylococcal enterocolitis following antibiotic therapy. Ann Surg (1963) 1.71
The prevalence of Clostridium difficile and toxin in a nursery population: a comparison between patients with necrotizing enterocolitis and an asymptomatic group. J Pediatr (1982) 1.71
Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis. Johns Hopkins Med J (1981) 1.69
Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture. Scand J Infect Dis Suppl (1980) 1.68
Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase. J Clin Microbiol (1991) 1.67
Colitis following oral lincomycin therapy. Arch Intern Med (1974) 1.66
Gas-liquid chromatography as screening test for Clostridium difficile. Lancet (1981) 1.63
Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A. J Med Microbiol (1991) 1.63
Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A. J Clin Microbiol (1992) 1.61
Detection of Clostridium difficile toxins A (enterotoxin) and B (cytotoxin) in clinical specimens. Evaluation of a latex agglutination test. Am J Clin Pathol (1986) 1.61
Antimicrobial agent-induced diarrhea--a bacterial disease. J Infect Dis (1977) 1.59
Detection of Clostridium difficile toxin by counterimmunoelectrophoresis: a note of caution. J Clin Microbiol (1981) 1.58
Anaerobes in men with urethritis. Br J Vener Dis (1982) 1.57
Comparison of bacterial isolation, cytotoxicity assay, and counterimmunoelectrophoresis for the detection of Clostridium difficile and its toxin. J Infect Dis (1983) 1.57
Nucleotide sequence of Clostridium difficile toxin A. Nucleic Acids Res (1990) 1.55
Clostridium difficile toxin A and its effects on cells. Toxicon (1991) 1.54
Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis (1982) 1.53
Isolation of Clostridium difficile from the feces and the antibody in sera of young and elderly adults. Microbiol Immunol (1981) 1.53
Comparison of Minitek Anaerobe II, API An-Ident, and RapID ANA systems for identification of Clostridium difficile. Am J Clin Pathol (1986) 1.53
Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia (2007) 1.52
Degradation of 2-phosphoglycerate by cytotoxin B of Clostridium difficile. FEBS Lett (1990) 1.42
The hemodialysis access: preferences and concerns of patients, dialysis nurses and technicians, and physicians. Am J Nephrol (1998) 1.04
A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily. Br J Cancer (1996) 1.03
Genotypic, clinical, and demographic characteristics of children infected with Helicobacter pylori. J Clin Microbiol (2001) 0.97
Pharmacologic action of Escherichia coli heat-stable (STa) enterotoxin. J Pharmacol Toxicol Methods (1992) 0.94
An algorithm for angiographic estimation of blood vessel diameter. J Appl Physiol (1985) (1991) 0.93
Affective disturbance in eating disorders. J Nerv Ment Dis (1985) 0.92
Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification. J Infect Dis (1998) 0.91
Length of stay and medical stability for spinal cord-injured patients on admission to an inpatient rehabilitation hospital: a comparison between a model SCI trauma center and non-SCI trauma center. Spinal Cord (2010) 0.88
T lymphocyte surface antigen markers in osteoporosis. J Bone Miner Res (1990) 0.87
The effect of small infarcts and carotid endarterectomy on postoperative psychologic test performance. J Surg Res (1980) 0.85
Assessing attachment: convergent validity of the adult attachment interview and the parental bonding instrument. Aust N Z J Psychiatry (1999) 0.83
Characteristics of Helicobacter pylori infection in Jamaican adults with gastrointestinal symptoms. J Clin Microbiol (2001) 0.83
General distress, hopelessness-suicidal ideation and worrying in adolescence: concurrent and predictive validity of a symptom-level bifactor model for clinical diagnoses. J Affect Disord (2013) 0.82
Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr. Transfusion (1992) 0.82
Effect of food on the pharmacokinetics and bioavailability of oral imiquimod relative to a subcutaneous dose. Int J Clin Pharmacol Ther (2000) 0.80
Muscle protein synthesis: regulation of a translational inhibitor. Am J Physiol (1984) 0.79
Anti-interleukin-4 inhibits immunoglobulin E production in a murine model of atopic asthma. J Asthma (1997) 0.79
A new chondrodystrophy mutation in Japanese quail (Coturnix japonica). J Hered (1990) 0.78
Effects of various fixatives and fixation conditions on DNA ploidy analysis. A need for strict internal DNA standards. Am J Clin Pathol (1991) 0.77
Ecological toxicology and human health effects of heptachlor. Rev Environ Contam Toxicol (1990) 0.77
Improved post-transfusion quality of density separated AS-3 red cells after extended storage. Br J Haematol (1992) 0.76
Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene. QJM (2011) 0.75
Timing of discontinuing SSRIs in OCD. J Am Acad Child Adolesc Psychiatry (1999) 0.75
Case report: hemolytic anemia produced by tolmetin. Immunohematology (1992) 0.75
Lanthanum inhibits surfactant secretion stimulated by lung distension in newborn rabbits. Pediatr Res (1991) 0.75
Public relations as a means of public education on the role of bariatric surgery. Obes Surg (2000) 0.75
Oncogenes and acute leukemias. Blood (1984) 0.75
Adenosine: the newest drug for PSVT. RN (1992) 0.75
Separate and together: all-black therapy group in the white hospital. Am J Orthopsychiatry (1974) 0.75
Leading the way. Nurs Elder (1990) 0.75
Intrathoracic extramedullary hematopoiesis secondary to B12 and folate deficiency: CT appearance. J Comput Assist Tomogr (1991) 0.75
Effects of water pollution by animal effluent. J Sci Food Agric (1972) 0.75
[Social rehabilitation of young thalidomide victims]. Infirm Can (1967) 0.75
Care of a woman with Down's syndrome using the Neuman Systems Model. Br J Nurs (1995) 0.75
Comparison of forces in high- and low-impact aerobic dance at various tempos. Am J Health Promot (1994) 0.75
Surfactant protein-A inhibits lavage-induced surfactant secretion in newborn rabbits. Am J Med Sci (1992) 0.75
Habilitation of thalidomide children: the nursing approach. Can Nurse (1967) 0.75
Mediastinal surgery in connective tissue tunnels using flexible endoscopy. Surg Endosc (2010) 0.75
An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma. Ir Med J (2009) 0.75
Effect of calcium and calcium antagonists on phospholipid secretion induced by lung inflation in newborn rabbits. Am J Med Sci (1991) 0.75